US 12053477
Methods for treating pulmonary fibrosis
granted A61KA61K31/538A61K9/0053
Quick answer
US patent 12053477 (Methods for treating pulmonary fibrosis) held by REVIVA PHARMACEUTICALS, INC. expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/538, A61K9/0053, A61P, A61P11/00